FTI Consulting (FCN) risk chief granted 153-share restricted stock award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FTI Consulting VP Matthew Pachman received an equity grant of 153 shares of common stock as a compensation award. The Form 4 classifies this as a grant or award acquisition, not a market purchase or sale, at a stated price of $0.00 per share.
The award is in the form of restricted stock units that vest over time, with 50% vesting on the first anniversary of the grant date and the remaining 50% on the second anniversary. After this grant, Pachman directly holds a total of 1,844 shares of FTI Consulting common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Pachman Matthew
Role
VP, Chief Risk/Ethics Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 153 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 1,844 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did FTI Consulting (FCN) report for Matthew Pachman?
FTI Consulting reported that VP and Chief Risk/Ethics Officer Matthew Pachman received a grant of 153 shares of common stock. The filing classifies this as a compensation-related award, not an open-market purchase or sale.
What type of award did Matthew Pachman receive from FTI Consulting (FCN)?
Matthew Pachman received restricted stock units representing 153 shares of FTI Consulting common stock. The Form 4 describes the transaction as a grant or award acquisition, reflecting equity-based compensation rather than a market trade.
What is the vesting schedule for Matthew Pachman’s FTI Consulting (FCN) restricted stock units?
The restricted stock units vest in two equal installments: 50% of the award vests on the first anniversary of the grant date and the remaining 50% vests on the second anniversary of the grant date, releasing equivalent common shares.
Was Matthew Pachman’s FTI Consulting (FCN) Form 4 transaction a stock purchase or sale?
The transaction was not an open-market purchase or sale. It was reported as an acquisition via grant or award of 153 shares at a stated price of $0.00 per share, reflecting compensation rather than a discretionary trade.